Jazz Pharmaceuticals Net Profit Margin 2007-2019 | JAZZ

Current and historical net profit margin for Jazz Pharmaceuticals (JAZZ) from 2007 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue. Jazz Pharmaceuticals net profit margin for the three months ending March 31, 2019 was .
Jazz Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-03-31 $1.95B $0.49B 24.83%
2018-12-31 $1.89B $0.45B 23.60%
2018-09-30 $1.85B $0.52B 28.05%
2018-06-30 $1.79B $0.43B 24.21%
2018-03-31 $1.69B $0.45B 26.56%
2017-12-31 $1.62B $0.49B 30.22%
2017-09-30 $1.58B $0.37B 23.69%
2017-06-30 $1.54B $0.40B 25.96%
2017-03-31 $1.53B $0.41B 26.77%
2016-12-31 $1.49B $0.40B 26.75%
2016-09-30 $1.43B $0.36B 25.42%
2016-06-30 $1.40B $0.36B 25.88%
2016-03-31 $1.35B $0.34B 24.78%
2015-12-31 $1.33B $0.33B 24.91%
2015-09-30 $1.31B $0.33B 25.08%
2015-06-30 $1.28B $0.27B 20.89%
2015-03-31 $1.24B $0.22B 18.06%
2014-12-31 $1.17B $0.06B 5.03%
2014-09-30 $1.08B $0.03B 2.96%
2014-06-30 $1.01B $0.08B 8.05%
2014-03-31 $0.92B $0.08B 8.56%
2013-12-31 $0.87B $0.22B 24.66%
2013-09-30 $0.82B $0.36B 44.02%
2013-06-30 $0.76B $0.32B 41.75%
2013-03-31 $0.68B $0.30B 44.71%
2012-12-31 $0.59B $0.29B 49.23%
2012-09-30 $0.49B $0.13B 25.67%
2012-06-30 $0.38B $0.12B 32.29%
2012-03-31 $0.33B $0.13B 40.00%
2011-12-31 $0.27B $0.12B 45.42%
2011-09-30 $0.24B $0.11B 45.87%
2011-06-30 $0.21B $0.09B 42.99%
2011-03-31 $0.19B $0.05B 28.04%
2010-12-31 $0.17B $0.03B 18.50%
2010-09-30 $0.16B $0.01B 8.86%
2010-06-30 $0.14B $-0.00B -0.69%
2010-03-31 $0.14B $0.01B 4.96%
2009-12-31 $0.13B $-0.01B -5.47%
2009-09-30 $0.11B $-0.07B -63.64%
2009-06-30 $0.10B $-0.10B -100.00%
2009-03-31 $0.08B $-0.15B -198.68%
2008-12-31 $0.07B $-0.19B -268.12%
2008-09-30 $0.06B $-0.19B -293.75%
2008-06-30 $0.07B $-0.18B -265.67%
2008-03-31 $0.07B $-0.17B -255.38%
2007-12-31 $0.06B $-0.14B -217.19%
2007-09-30 $0.05B $-0.08B -161.22%
2007-06-30 $0.04B $-0.05B -133.33%
2007-03-31 $0.04B $-0.04B -100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.838B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.928B 31.26
Takeda Pharmaceutical (TAK) Japan $28.138B 10.41
Grifols (GRFS) Spain $12.431B 15.72
Ionis Pharmaceuticals (IONS) United States $9.466B 20.69
Sage Therapeutics (SAGE) United States $8.358B 0.00
Neurocrine Biosciences (NBIX) United States $7.000B 0.00
Catalent (CTLT) United States $6.611B 26.53
Nektar Therapeutics (NKTR) United States $5.604B 9.13
Tilray (TLRY) Canada $4.276B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.953B 12.73
United Therapeutics (UTHR) United States $3.851B 0.00
FibroGen (FGEN) United States $3.087B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.467B 8.88
PTC Therapeutics (PTCT) United States $2.185B 0.00
Portola Pharmaceuticals (PTLA) United States $1.947B 0.00
Xencor (XNCR) United States $1.849B 50.48
Aerie Pharmaceuticals (AERI) United States $1.798B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.796B 270.57
Pacira Pharmaceuticals (PCRX) United States $1.789B 86.64
Tricida (TCDA) United States $1.779B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.776B 24.27
USANA Health Sciences (USNA) United States $1.769B 15.37
Ironwood Pharmaceuticals (IRWD) United States $1.724B 0.00
Zogenix (ZGNX) United States $1.580B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.538B 0.00
Endo (ENDP) Ireland $1.411B 2.27
Heron Therapeutics (HRTX) United States $1.410B 0.00
Esperion Therapeutics (ESPR) United States $1.348B 0.00
Corcept Therapeutics (CORT) United States $1.218B 17.38
Theravance Biopharma (TBPH) Cayman Islands $1.114B 0.00
TURNING PT THER (TPTX) United States $1.082B 0.00
Radius Health (RDUS) United States $0.904B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.862B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.815B 0.00
TherapeuticsMD (TXMD) United States $0.794B 0.00
ArQule (ARQL) United States $0.738B 0.00
Aptorum Group (APM) China $0.695B 0.00
ChemoCentryx (CCXI) United States $0.686B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.637B 0.00
Akebia Therapeutics (AKBA) United States $0.636B 0.00
ORGANOGENESIS (ORGO) United States $0.626B 0.00
CannTrust Holdings (CTST) Canada $0.616B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.610B 0.00
Odonate Therapeutics (ODT) United States $0.598B 0.00
Dermira (DERM) United States $0.541B 0.00
GlycoMimetics (GLYC) United States $0.510B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.475B 0.00
Flexion Therapeutics (FLXN) United States $0.475B 0.00
Siga Technologies (SIGA) United States $0.462B 1.09
BioSpecifics Technologies Corp (BSTC) United States $0.462B 23.33
Translate Bio (TBIO) United States $0.452B 0.00
Mast Therapeutics (SVRA) United States $0.405B 0.00
Collegium Pharmaceutical (COLL) United States $0.400B 0.00
KalVista Pharmaceuticals (KALV) United States $0.397B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.390B 0.00
Forty Seven (FTSV) United States $0.385B 0.00
OptiNose (OPTN) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.341B 0.00
TCR2 Therapeutics (TCRR) United States $0.336B 0.00
Xeris Pharmaceuticals (XERS) United States $0.334B 0.00
Karyopharm Therapeutics (KPTI) United States $0.313B 0.00
CASI Pharmaceuticals (CASI) United States $0.302B 0.00
ImmunoGen (IMGN) United States $0.290B 0.00
Dova Pharmaceuticals (DOVA) United States $0.288B 0.00
Molecular Templates (MTEM) United States $0.280B 0.00
Harpoon Therapeutics (HARP) United States $0.271B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.260B 0.00
Concert Pharmaceuticals (CNCE) United States $0.250B 0.00
Aratana Therapeutics (PETX) United States $0.238B 0.00
Lannett Co Inc (LCI) United States $0.236B 2.29
MEI Pharma (MEIP) United States $0.235B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.228B 0.00
Calithera Biosciences (CALA) United States $0.227B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.226B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.226B 0.00
Minerva Neurosciences (NERV) United States $0.224B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.223B 0.00
Aclaris Therapeutics (ACRS) United States $0.218B 0.00
Rafael Holdings (RFL) United States $0.214B 0.00
Galectin Therapeutics (GALT) United States $0.213B 0.00
Recro Pharma (REPH) United States $0.199B 0.00
IMV INC (IMV) Canada $0.197B 0.00
Aldeyra Therapeutics (ALDX) United States $0.196B 0.00
Opexa Therapeutics (ACER) United States $0.196B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 59.00
Ardelyx (ARDX) United States $0.180B 0.00
Majesco Entertainment (PTE) United States $0.171B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.169B 0.00
Redhill Biopharma (RDHL) Israel $0.162B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.157B 0.00
Jounce Therapeutics (JNCE) United States $0.155B 0.00
Tyme Technologies (TYME) United States $0.152B 0.00
Ocular Therapeutix (OCUL) United States $0.144B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.144B 0.00
Neon Therapeutics (NTGN) United States $0.144B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.144B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Aquestive Therapeutics (AQST) United States $0.134B 0.00
Bio Blast Pharma (ENLV) Israel $0.129B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.125B 0.00
AgeX Therapeutics (AGE) United States $0.121B 0.00
DURECT (DRRX) United States $0.118B 0.00
MediWound (MDWD) Israel $0.118B 0.00
Nivalis Therapeutics (ALPN) United States $0.107B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.106B 75.56
ProNAi Therapeutics (SRRA) Canada $0.105B 0.00
Cardiome Pharma (CORV) Canada $0.099B 0.00
Iterum Therapeutics (ITRM) Ireland $0.098B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Natural Alternatives (NAII) United States $0.096B 9.56
ElectroCore (ECOR) United States $0.092B 0.00
Zafgen (ZFGN) United States $0.092B 0.00
China SXT Pharmaceuticals (SXTC) China $0.090B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.086B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Neos Therapeutics (NEOS) United States $0.085B 0.00
Infinity Pharmaceuticals (INFI) United States $0.084B 0.00
Otonomy (OTIC) United States $0.082B 0.00
Adherex Technologies (FENC) United States $0.079B 0.00
Avenue Therapeutics (ATXI) United States $0.077B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
Genocea Biosciences (GNCA) United States $0.075B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.074B 0.00
Capnia (SLNO) United States $0.064B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.050B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.049B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.049B 0.00
Novan (NOVN) United States $0.049B 0.00
AIT Therapeutics (AITB) Israel $0.047B 0.00
India Globalization Capital (IGC) United States $0.046B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.043B 0.00
Bio-Path Holdings (BPTH) United States $0.043B 0.00
KemPharm (KMPH) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
ContraFect (CFRX) United States $0.036B 0.00
Melinta Therapeutics (MLNT) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
IsoRay (ISR) United States $0.030B 0.00
Citius Pharmaceuticals (CTXR) United States $0.029B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.027B 0.00
HANCOCK JAFFE (HJLI) United States $0.027B 0.00
Regulus Therapeutics (RGLS) United States $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.024B 3.11
Achieve Life Sciences (ACHV) United States $0.023B 0.00
PharmAthene (ALT) United States $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Biomerica (BMRA) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.018B 0.00
Pain Therapeutics (SAVA) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 2.69
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Trillium Therapeutics (TRIL) Canada $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.97
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.007B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.007B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00